Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Joern Treuner"'
Autor:
Barbara Hero, Joern Treuner, Claudia Spix, Rudolf Erttmann, Joerg Michaelis, Freimut H. Schilling, Angela Ernst, Frank Berthold
Publikováno v:
JNCI Cancer Spectrum
Background Neuroblastoma screening aims to reduce neuroblastoma-related mortality. A controlled trial showed no reduction in stage 4 disease incidence and preliminary mortality data. This article presents epidemiologic and clinical data 20 years afte
Autor:
Andreas Schuck, Thomas Klingebiel, Ivo Leuschner, Adrian C. Mattke, Joern Treuner, Emily J. Bailey, Ewa Koscielniak, Tobias M. Dantonello
Publikováno v:
Pediatric Blood & Cancer. 52:772-776
Background: Childhood rhabdomyosarcoma (RMS), a soft tissue malignant tumor of skeletal muscle origin, accounts for approximately 3.5% of the cases of cancer among children 0–14 years and 2% of the cases among adolescents and young adults 15–19 y
Autor:
Ines B. Brecht, Ivo Leuschner, Tobias M. Dantonello, Heribert Juergens, Manfred Herbst, Sylvia Kirsch, Christoph Int-Veen, Helmut Gadner, Stefan S. Bielack, Ewa Koscielniak, Michael Greulich, Ildiko Marky, Dieter Harms, Rainer Schmelzle, Roswitha Dickerhoff, Thomas Klingebiel, Bernhard F. Schmidt, Jeanette Greiner, Hans-Gerhard Scheel-Walter, Joern Treuner
Publikováno v:
Journal of Clinical Oncology. 27:1446-1455
Purpose To improve risk-adapted therapy for localized childhood soft tissue sarcoma within an international multicenter setting. Patients and Methods Four hundred forty-one patients younger than 21 years with localized rhabdomyosarcoma and rhabdomyos
Autor:
Bernarda Kazanowska, Helmut Gadner, Ewa Koscielniak, Christoph Int-Veen, Erika Hallmen, Joern Treuner, Ildiko Marky, Thomas Klingebiel, Florian Beske, Joachim Boos, Tobias M. Dantonello
Publikováno v:
Pediatric Blood & Cancer. 50:739-745
Purpose We prospectively studied the efficacy of high dose therapy (HDT) versus an oral maintenance treatment (OMT) in patients with stage IV soft tissue sarcoma (STS). Patients and Methods Both groups were pretreated with the CEVAIE combination cons
Autor:
Tobias M. Dantonello, Sylvia Kirsch, Stefan S. Bielack, Ivo Leuschner, Bernarda Kazanowska, Ruth Ladenstein, Bernhard F. Schmidt, T. Klingebiel, Thomas Wiebe, Christoph Int-Veen, Joern Treuner, Iris Veit-Friedrich, Helmut Lochbuehler, Felix Niggli, Andreas Schuck, Peter Winkler, Ewa Koscielniak, Erika Hallmen
Publikováno v:
Journal of Clinical Oncology. 26:406-413
Purpose Evaluation of primary tumor-, treatment-, and patient-related factors predicting relapse pattern, risk, and survival after relapse with the aim to design a risk-adapted, tumor-directed surveillance program for patients with localized rhabdomy
Autor:
Frank Berthold, Rudolf Erttmann, Joern Treuner, Johannes Sander, Claudia Spix, Freimut H. Schilling, Joerg Michaelis
Publikováno v:
Cancer Letters. 197:19-28
Neuroblastoma is the second most frequent malignancy in childhood. We investigated whether screening for neuroblastoma at 1 year of age reduces the incidence of metastatic disease or mortality. Screening was offered in 6 of the 16 German states from
Autor:
Beverly Raney, Alp Ozkan, Adrian C. Mattke, Alvida M. Cain, Mark F. Munsell, Mehmet Fatih Okcu, Alberto S. Pappo, Michela Casanova, Andrea Ferrari, Joern Treuner
Publikováno v:
Journal of Clinical Oncology. 21:1602-1611
Purpose: To identify prognostic factors related to outcome in 219 children and adolescents with synovial sarcoma. Patients and Methods: We combined the experiences of the four following research groups: Cooperative Weichteilsarkomastudie Group, Germa
Autor:
Barbara Hero, Kerstin Schwarz, Rudolf Erttmann, Ulrich Zorn, Frank Berthold, Claudia Spix, Freimut H. Schilling, Joerg Michaelis, Gisela Klein, Johannes Sander, N. Fehse, Joern Treuner
Publikováno v:
New England Journal of Medicine. 346:1047-1053
Background Neuroblastoma is the second most common type of childhood tumor. It is not known whether screening for neuroblastoma at one year of age reduces the incidence of metastatic disease or mortality due to neuroblastoma. Methods We offered urine
Autor:
Peter Bader, Thomas Klingebiel, Ewa Koscielniak, Peter Lang, Peter Winkler, Joern Treuner, Rupert Handgretinger, Dietrich Niethammer, Ute Gross-Wieltsch
Publikováno v:
Journal of Clinical Oncology. 23:242-244
TO THE EDITOR: The chance of cure is very low for patients with primary metastatic or relapsed rhabdomyosarcoma or Ewing tumors. 1-3 In the German multicenter studies CWS-81, -86, -91, and -96, patients older than 10 years at diagnosis with bone or b
Autor:
Joern Treuner, Ewa Koscielniak, Andrea Ferrari, Gianni Bisogno, Adrian C. Mattke, Michela Casanova, Modesto Carli, Christoph Int-Veen, Andreas Schuck, Ines B. Brecht
Publikováno v:
Pediatric bloodcancer. 46(1)
Differently from adult oncologists that considered synovial sarcoma (SS) a tumor with uncertain chemosensitiveness, since two decades pediatric oncologists in Europe assumed that chemotherapy played an important role in SS treatment, so most pediatri